Grants and Contributions:

Back to search
Title:
Covid-19: Design of a Contract Manufacturing Vaccine/Biomanufacturing Fill-Finish Facility
Agreement Number:
958184
Agreement Value:
$500,000.00
Agreement Date:
Sep 8, 2020 - Sep 30, 2021
Description:
Design of a facility, inclusive of engineering design and research in innovative formulation and fill-finish manufacturing of vaccines, therapies and other biopharmaceuticals using a Ready-To-Use (RTU) container platform for vials and prefilled syringes. Novocol Pharma is a world-class commercial aseptic fill-finish operation with multiple fill-finish suites and scientific/technical support departments (Microbiology, Chemistry, Product Development, Engineering, Validation, Stability and Analytical Services). An existing warehouse building will be renovated to create injectable vaccine/therapy fill-finish operations with two formulation/ filling clean rooms, each equipped with innovative aseptic VanRx filling work cells... see attachment
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Cambridge, Ontario, CA N1R 6X3
Reference Number:
172-2020-2021-Q3-958184
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
103950481
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 184 days.

Amendment Date
Feb 5, 2021
Recipient's Operating Name:
Septodont
Recipient's Legal Name:
Novocol Pharmaceutical of Canada Inc.
Federal Riding Name:
Cambridge
Federal Riding Number:
35016
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541
Amendments:
See Amendments